Results 51 to 60 of about 1,308,546 (203)

Real‐World Survival Outcomes of Venetoclax Combination Therapies in Acute Myeloid Leukemia: Impact of Minimal Residual Disease Status and Antifungal Prophylaxis

open access: yesHematological Oncology, Volume 44, Issue 6, November 2026.
ABSTRACT In recent years the addition of the oral BCL2 inhibitor venetoclax to hypomethylating agents (HMAs) has emerged as the standard‐of‐care for patients with acute myeloid leukemia (AML) who are not fit for intensive chemotherapy, significantly improving survival and quality‐of‐life.
Mariarita Sciumè   +9 more
wiley   +1 more source

Invasive Pulmonary Aspergillosis-mimicking Tuberculosis [PDF]

open access: yesClinical Infectious Diseases, 2015
Pulmonary tuberculosis is occasionally confused with invasive pulmonary aspergillosis (IPA) in transplant recipients, since clinical suspicion and early diagnosis of pulmonary tuberculosis and IPA rely heavily on imaging modes such as computed tomography (CT).
Sung-Han, Kim   +9 more
openaire   +2 more sources

Mixed Invasive Fungal Pneumonia Caused by Aspergillus, Candida, Mucor in an Immunocompromised Host

open access: yesRespirology Case Reports, Volume 14, Issue 11, November 2026.
We report a case of mixed invasive fungal pneumonia caused by Aspergillus, Candida and Mucor species in an immunocompromised host, highlighting the diagnostic and therapeutic implications of concurrent opportunistic fungal infections. ABSTRACT Invasive fungal pneumonia (IFP) is a life‐threatening complication in immunocompromised patients, particularly
Taeyun Kim   +6 more
wiley   +1 more source

Successful surgical management of invasive aspergillosis of the pulmonary arteries

open access: yes, 2008
We describe an 11-year-old girl with severe obstruction of the main pulmonary arteries caused by invasive aspergillosis and managed with combined pulmonary endarterectomy and antimycotic ...
R. Dore   +6 more
core   +1 more source

COVID-19 associated pulmonary aspergillosis in ICU patients: Report of five cases from Argentina

open access: yesMedical Mycology Case Reports, 2021
Invasive pulmonary aspergillosis is a complication in critically ill patients with acute respiratory distress syndrome, especially those with severe coronavirus disease-associated pneumonia.
María Fernanda Benedetti   +8 more
doaj   +1 more source

Real‐World Use of Rezafungin for the Treatment of Challenging Aspergillus Infections

open access: yesMycoses, Volume 69, Issue 11, November 2026.
ABSTRACT Background Aspergillus infections can pose significant treatment challenges, due in part to increasing triazole resistance. Clinical insight is needed to understand the potential for rezafungin, a next‐generation echinocandin with once‐weekly dosing, to address some limitations of current treatments for Aspergillus infections.
Neil Stone   +9 more
wiley   +1 more source

Rhino‐Orbital Mucormycosis in an Immunocompetent Adult: A Case Report Emphasizing Diagnostic and Therapeutic Challenges

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Rhino‐orbital mucormycosis can present aggressively in immunocompetent adults, often with atypical initial symptoms that lead to misdiagnosis and dangerous delays. A high index of suspicion is paramount when facing a rapidly progressive orbital infection unresponsive to conventional therapy.
Seyed Mohammad Mousavi   +5 more
wiley   +1 more source

Influenza-associated pulmonary aspergillosis in a patient on ECMO

open access: yesMedical Mycology Case Reports, 2020
Invasive pulmonary aspsergillosis (IPA) is a well-known disease typically affecting severely immunocompromised patients. Recently, IPA has been described in a new group of patients such as those infected with influenza.
Khaled Alobaid   +2 more
doaj   +1 more source

Case series of invasive lung infections by Aspergillus species and zygomycosis among post COVID-19 and post-transplant individuals

open access: yesJournal of Family Medicine and Primary Care, 2022
Airborne pathogens like Aspergillus bring the lungs in the frontline for defense. Pulmonary diseases caused by Aspergillus species are broadly classified as aspergilloma, chronic necrotizing pulmonary aspergillosis, invasive pulmonary aspergillosis (IPA),
Mayuri Mahajan   +3 more
doaj   +1 more source

Interpretable Machine Learning Model for Fungal Infection Prediction: A Real‐World Study

open access: yesHealth Care Science, Volume 5, Issue 5, Page 473-486, October 2026.
Our study successfully developed and validated a machine learning model based on large‐scale electronic health record data to predict the risk of fungal infections in hospitalized patients. Through a Streamlit‐powered web platform, the model was seamlessly embedded into clinical workflows, completing the full pipeline from model construction to real ...
Jinru Yang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy